317 related articles for article (PubMed ID: 16253503)
1. Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cells.
Binz N; Shalaby T; Rivera P; Shin-ya K; Grotzer MA
Eur J Cancer; 2005 Dec; 41(18):2873-81. PubMed ID: 16253503
[TBL] [Abstract][Full Text] [Related]
2. A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia.
Sumi M; Tauchi T; Sashida G; Nakajima A; Gotoh A; Shin-Ya K; Ohyashiki JH; Ohyashiki K
Int J Oncol; 2004 Jun; 24(6):1481-7. PubMed ID: 15138591
[TBL] [Abstract][Full Text] [Related]
3. The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures.
Kim MY; Gleason-Guzman M; Izbicka E; Nishioka D; Hurley LH
Cancer Res; 2003 Jun; 63(12):3247-56. PubMed ID: 12810655
[TBL] [Abstract][Full Text] [Related]
4. Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia.
Tauchi T; Shin-ya K; Sashida G; Sumi M; Okabe S; Ohyashiki JH; Ohyashiki K
Oncogene; 2006 Sep; 25(42):5719-25. PubMed ID: 16652154
[TBL] [Abstract][Full Text] [Related]
5. [Telomerase inhibitor, telomestatin, a specific mechanism to interact with telomere structure].
Shin-ya K
Nihon Rinsho; 2004 Jul; 62(7):1277-82. PubMed ID: 15283144
[TBL] [Abstract][Full Text] [Related]
6. Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase.
Gomez D; Aouali N; Renaud A; Douarre C; Shin-Ya K; Tazi J; Martinez S; Trentesaux C; Morjani H; Riou JF
Cancer Res; 2003 Oct; 63(19):6149-53. PubMed ID: 14559794
[TBL] [Abstract][Full Text] [Related]
7. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Kelland LR
Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
[TBL] [Abstract][Full Text] [Related]
9. Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways.
Tauchi T; Shin-Ya K; Sashida G; Sumi M; Nakajima A; Shimamoto T; Ohyashiki JH; Ohyashiki K
Oncogene; 2003 Aug; 22(34):5338-47. PubMed ID: 12917635
[TBL] [Abstract][Full Text] [Related]
10. Affinity and selectivity of G4 ligands measured by FRET.
De Cian A; Guittat L; Shin-ya K; Riou JF; Mergny JL
Nucleic Acids Symp Ser (Oxf); 2005; (49):235-6. PubMed ID: 17150720
[TBL] [Abstract][Full Text] [Related]
11. G-Quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3' telomeric overhang in cancer cells.
Tahara H; Shin-Ya K; Seimiya H; Yamada H; Tsuruo T; Ide T
Oncogene; 2006 Mar; 25(13):1955-66. PubMed ID: 16302000
[TBL] [Abstract][Full Text] [Related]
12. Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss.
Ji HJ; Rha SY; Jeung HC; Yang SH; An SW; Chung HC
Breast Cancer Res Treat; 2005 Oct; 93(3):227-36. PubMed ID: 16132531
[TBL] [Abstract][Full Text] [Related]
13. Arsenic induces telomerase expression and maintains telomere length in human cord blood cells.
Ferrario D; Collotta A; Carfi M; Bowe G; Vahter M; Hartung T; Gribaldo L
Toxicology; 2009 Jun; 260(1-3):132-41. PubMed ID: 19464579
[TBL] [Abstract][Full Text] [Related]
14. Identification of a quinoxaline derivative that is a potent telomerase inhibitor leading to cellular senescence of human cancer cells.
Kim JH; Kim JH; Lee GE; Kim SW; Chung IK
Biochem J; 2003 Jul; 373(Pt 2):523-9. PubMed ID: 12689331
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis and inhibition of telomerase activity in human bone marrow and HL-60 p53 null cells treated with anti-cancer drugs.
Malerba I; Gribaldo L; Diodovich C; Carloni M; Meschini R; Bowe G; Collotta A
Toxicol In Vitro; 2005 Jun; 19(4):523-32. PubMed ID: 15826810
[TBL] [Abstract][Full Text] [Related]
16. Distinct modulation of telomere length in two T-lymphoblastic leukemia cell lines by cytotoxic nucleoside phosphonates PMEG and PMEDAP.
Hájek M; Cvilink V; Votruba I; Holý A; Mertlíková-Kaiserová H
Eur J Pharmacol; 2010 Sep; 643(1):6-12. PubMed ID: 20599933
[TBL] [Abstract][Full Text] [Related]
17. [Role of human telomerase reverse transcriptase in apoptosis of human umbilical vein endothelial cells induced by trichostatin A].
Wu P; Xi L; Chen G; Wang BB; Luo DF; Lu YP; Zhou JF; Ma D
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):334-7. PubMed ID: 17892126
[TBL] [Abstract][Full Text] [Related]
18. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis by (Z)-stellettic acid C, an acetylenic acid from the sponge Stelletta sp., is associated with inhibition of telomerase activity in human leukemic U937 cells.
Park C; Kim GY; Kim WI; Hong SH; Park DI; Kim ND; Bae SJ; Jung JH; Choi YH
Chemotherapy; 2007; 53(3):160-8. PubMed ID: 17356266
[TBL] [Abstract][Full Text] [Related]
20. The telomerase inhibitor telomestatin induces telomere shortening and cell death in Arabidopsis.
Zhang L; Tamura K; Shin-ya K; Takahashi H
Biochim Biophys Acta; 2006 Jan; 1763(1):39-44. PubMed ID: 16473138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
